Circular RNA startup Orbital unveils first monkey data as it enters in vivo CAR-T cell therapy race

Orbital Therapeutics, a well-funded but secretive startup developing a next-generation version of mRNA technology called circular RNA, shared its first preclinical data in an interview with Endpoints News ahead of a conference ...